BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 31616148)

  • 1. Real-World Treatment Patterns and Adherence to Oral Medication Among Patients with Bipolar Disorders: A Retrospective, Observational Study Using a Healthcare Claims Database.
    Inoue T; Sano H; Kojima Y; Yamada S; Shirakawa O
    Neuropsychiatr Dis Treat; 2021; 17():821-833. PubMed ID: 33776438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two randomized, double-blind, placebo-controlled trials and one open-label, long-term trial of brexpiprazole for the acute treatment of bipolar mania.
    Vieta E; Sachs G; Chang D; Hellsten J; Brewer C; Peters-Strickland T; Hefting N
    J Psychopharmacol; 2021 Aug; 35(8):971-982. PubMed ID: 33691517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Process and Outcome Evaluations of Smartphone Apps for Bipolar Disorder: Scoping Review.
    Tatham I; Clarke E; Grieve KA; Kaushal P; Smeddinck J; Millar EB; Sharma AN
    J Med Internet Res; 2022 Mar; 24(3):e29114. PubMed ID: 35319470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Initiation of aripiprazole once-monthly in patients with schizophrenia.
    Raoufinia A; Baker RA; Eramo A; Nylander AG; Landsberg W; Kostic D; Larsen F
    Curr Med Res Opin; 2015 Mar; 31(3):583-92. PubMed ID: 25586294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A clinical review of aripiprazole in bipolar depression and maintenance therapy of bipolar disorder.
    Yatham LN
    J Affect Disord; 2011 Jan; 128 Suppl 1():S21-8. PubMed ID: 21220077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of the Functioning Assessment Short Test (FAST) in defining functional recovery in bipolar I disorder. Post-hoc analyses of long-term studies of aripiprazole once monthly as maintenance treatment.
    Madera J; Such P; Zhang P; Baker RA; Grande I
    Neuropsychiatr Dis Treat; 2019; 15():2325-2338. PubMed ID: 31616148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Symptoms and functioning with aripiprazole once-monthly injection as maintenance treatment for bipolar I disorder.
    Calabrese JR; Sanchez R; Jin N; Amatniek J; Cox K; Johnson B; Perry P; Hertel P; Such P; McQuade RD; Nyilas M; Carson WH
    J Affect Disord; 2018 Feb; 227():649-656. PubMed ID: 29174738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and Safety of Aripiprazole Once-Monthly in the Maintenance Treatment of Bipolar I Disorder: A Double-Blind, Placebo-Controlled, 52-Week Randomized Withdrawal Study.
    Calabrese JR; Sanchez R; Jin N; Amatniek J; Cox K; Johnson B; Perry P; Hertel P; Such P; Salzman PM; McQuade RD; Nyilas M; Carson WH
    J Clin Psychiatry; 2017 Mar; 78(3):324-331. PubMed ID: 28146613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The safety and tolerability of aripiprazole once-monthly as maintenance treatment for bipolar I disorder: A double-blind, placebo-controlled, randomized withdrawal study.
    Calabrese JR; Sanchez R; Jin N; Amatniek J; Cox K; Johnson B; Perry PP; Hertel P; Such P; McQuade RD; Nyilas M; Carson WH
    J Affect Disord; 2018 Dec; 241():425-432. PubMed ID: 30145513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of aripiprazole once-monthly on personal and social functioning: post hoc analyses of acute and long-term studies.
    Peters-Strickland T; Baker RA; Such P; Zhang P; Madera JJ
    Neuropsychiatr Dis Treat; 2019; 15():1659-1669. PubMed ID: 31296992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thresholds for severity, remission and recovery using the functioning assessment short test (FAST) in bipolar disorder.
    Bonnín CM; Martínez-Arán A; Reinares M; Valentí M; Solé B; Jiménez E; Montejo L; Vieta E; Rosa AR
    J Affect Disord; 2018 Nov; 240():57-62. PubMed ID: 30053684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aripiprazole once-monthly as maintenance treatment for bipolar I disorder: a 52-week, multicenter, open-label study.
    Calabrese JR; Jin N; Johnson B; Such P; Baker RA; Madera J; Hertel P; Ottinger J; Amatniek J; Kawasaki H
    Int J Bipolar Disord; 2018 Jun; 6(1):14. PubMed ID: 29886522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bipolar disorders.
    Vieta E; Berk M; Schulze TG; Carvalho AF; Suppes T; Calabrese JR; Gao K; Miskowiak KW; Grande I
    Nat Rev Dis Primers; 2018 Mar; 4():18008. PubMed ID: 29516993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneity of functional outcomes in patients with bipolar disorder: a cluster-analytic approach.
    Solé B; Bonnin CM; Jiménez E; Torrent C; Torres I; Varo C; Valls E; Montejo L; Gómez-Ocaña C; Tomioka Y; Vieta E; Martinez-Aran A; Reinares M
    Acta Psychiatr Scand; 2018 Jun; 137(6):516-527. PubMed ID: 29508379
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.